Clin2
NCT07350564Possibly a fitRecruiting

Comparing tight vs. usual blood pressure control after stroke clot removal

Stroke

Part of Brain & nervous system, Heart & circulation clinical trials.

This trial tests whether keeping blood pressure very tightly controlled after a stroke clot removal (thrombectomy) is better than standard care. It may help people who have had an acute stroke from a large brain artery blockage and still have high blood pressure after the procedure.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
910 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You had a stroke caused by a blockage in a major artery in the front part of your brain.
  • You had a procedure (thrombectomy) to remove the clot within 24 hours of your first symptoms.
  • The clot removal was successful, and you have no significant narrowing remaining in that artery.
  • Within 3 hours after the procedure, your blood pressure stayed high (systolic 140 or above) for at least two readings taken more than 10 minutes apart.
  • You do not have major liver or kidney problems, brain tumors, or other serious illnesses that would limit your life expectancy to less than 6 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07279259Recruiting· Phase 2
Blood pressure management after stroke clot-dissolving treatment

This trial tests how managing high blood pressure during clot-dissolving treatment for acute ischemic stroke affects recovery. It is for patients who have high blood pressure at the start of treatment.

Shanghai
NCT07476898Not yet recruiting· Phase 3
Precision clot treatment for disabling minor stroke with large vessel blockage beyond time window

This trial tests a specialized clot-removal treatment for people who had a mild but disabling stroke up to 24 hours ago and have a large artery blockage in the brain. The goal is to see if this precision therapy can help reduce disability and improve recovery.

Fuzhou, Fujian
NCT05911568Recruiting
Clot-removal treatment for stroke patients with existing disability

This trial studies whether an endovascular (catheter-based) procedure to treat a certain type of blocked artery can improve outcomes for people who already had trouble functioning before their stroke. You may be considered if your stroke is confirmed early and your scans show the right type and location of blockage.

Phoenix, Arizona
NCT06143488Recruiting
Clot removal vs. best medicine for mild stroke with large vessel blockage

This trial tests whether removing a blood clot from a large brain artery is better than standard medical care for people who have a mild stroke (NIHSS score 2-5) but still have symptoms like trouble speaking, weakness, or confusion. It is for patients who can be treated within 24 hours of their last known well time.

Wuhu, Anhui
NCT07527013Not yet recruiting· Phase 3
Blood Pressure Management After Stroke Clot Removal

This study tests whether keeping blood pressure at different target levels after emergency clot-removal treatment (called endovascular therapy) can improve recovery from acute ischemic stroke caused by large vessel blockages. The trial will help doctors understand the best blood pressure strategy for patients in the hours right after successful clot removal.

Beijing, Beijing Municipality
NCT06677970Recruiting· Phase 3
Blood Pressure Control After Stroke Thrombectomy

This trial tests whether carefully lowering blood pressure after a mechanical clot removal procedure for stroke can improve outcomes. If you've had a large vessel stroke that was successfully treated with thrombectomy, this study will help guide blood pressure management in the recovery period.

Seoul, Seoul

Hear when a new Stroke trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.